These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Study of a role of artificial mycobacterial particles in the realization of immunological processes in experimental animal tuberculosis]. Azaev MSh; Lebedev LR; Kuz'micheva GA; Tumanov IuV; Donchenko NA; Tat'kov SI; Nosareva OV; Il'ichev AA Probl Tuberk Bolezn Legk; 2007; (2):38-42. PubMed ID: 17419334 [TBL] [Abstract][Full Text] [Related]
5. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Derrick SC; Yang AL; Morris SL Vaccine; 2004 Dec; 23(6):780-8. PubMed ID: 15542202 [TBL] [Abstract][Full Text] [Related]
6. Optimal models to evaluate the protective efficacy of tuberculosis vaccines. Griffin JF; Chinn DN; Rodgers CR; Mackintosh CG Tuberculosis (Edinb); 2001; 81(1-2):133-9. PubMed ID: 11463234 [TBL] [Abstract][Full Text] [Related]
7. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs. Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606 [TBL] [Abstract][Full Text] [Related]
8. [Active immunization tests with Salvioli's vaccine in the course of experimental tuberculosis in guinea pigs]. Fafrowicz B; Dominiczak K; Szmygin J Ann Acad Med Stetin; 1971; 17():353-60. PubMed ID: 5149565 [No Abstract] [Full Text] [Related]
9. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. Kita Y; Tanaka T; Yoshida S; Ohara N; Kaneda Y; Kuwayama S; Muraki Y; Kanamaru N; Hashimoto S; Takai H; Okada C; Fukunaga Y; Sakaguchi Y; Furukawa I; Yamada K; Inoue Y; Takemoto Y; Naito M; Yamada T; Matsumoto M; McMurray DN; Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Skeiky Y; Reed S; Sakatani M; Okada M Vaccine; 2005 Mar; 23(17-18):2132-5. PubMed ID: 15755583 [TBL] [Abstract][Full Text] [Related]
10. BCG vaccine responses following simultaneous immunization against influenza and tuberculosis. 2nd report. Zykov MP; Subbotina TI; Kaplin NN Z Erkr Atmungsorgane; 1981 May; 157(2):165-80. PubMed ID: 6797135 [TBL] [Abstract][Full Text] [Related]
11. Tuberculosis: looking beyond BCG vaccines. Mustafa Abu S; Al-Attiyah R J Postgrad Med; 2003; 49(2):134-40. PubMed ID: 12867689 [TBL] [Abstract][Full Text] [Related]
12. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269 [TBL] [Abstract][Full Text] [Related]
13. [Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis]. Yamamoto T; Phalen S; Uchida K; Umemori K; Nojima Y; Horiuchi Y; Goto Y; McMurray DN; Yamamoto S Kekkaku; 2000 May; 75(5):379-88. PubMed ID: 10853313 [TBL] [Abstract][Full Text] [Related]
14. [Development of protective antituberculosis immunity after BCG vaccination in mice with silicon deficiency in water and feed]. Akuginova ZD; Akuginova GE; Mezhlumova MB; Avdienko VG; Nikonenko BV Probl Tuberk; 1995; (2):23-4. PubMed ID: 7777456 [TBL] [Abstract][Full Text] [Related]
15. [Effect of thymus preparations on the efficacy of postvaccinal immunity in experimental tuberculosis]. Kononko IV Fiziol Zh (1978); 1986; 32(4):478-81. PubMed ID: 3743824 [No Abstract] [Full Text] [Related]
16. Protective effect of BCG vaccination against various types of tuberculous disease. Wallgren A Bull Int Union Tuberc; 1966 Jun; 38(1):7-15. PubMed ID: 5927683 [No Abstract] [Full Text] [Related]
17. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Olsen AW; Hansen PR; Holm A; Andersen P Eur J Immunol; 2000 Jun; 30(6):1724-32. PubMed ID: 10898510 [TBL] [Abstract][Full Text] [Related]
18. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250 [TBL] [Abstract][Full Text] [Related]
19. Influence of V.D.S. (diffusible killed antitubercular vaccine Salvioli) on the course of experimental tuberculosis in guinea-pigs evoked by H 37 Rv strain bacilli. Fafrowicz B; Szmygin J Clin Pediatr (Bologna); 1970 Jul; 52(7):299-302. PubMed ID: 4998498 [No Abstract] [Full Text] [Related]
20. BCG and prospects for new vaccines against tuberculosis. Ortona L; De Luca A Rays; 1998; 23(1):225-30. PubMed ID: 9673148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]